---
layout: post
title: "Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same; Notice of Request for Submissions on the Public Interest"
date: 2026-02-05 18:58:48 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-07904
original_published: 2022-04-13 00:00:00 +0000
significance: 8.00
---

# Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same; Notice of Request for Submissions on the Public Interest

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** April 13, 2022 00:00 UTC
**Document Number:** 2022-07904

## Summary

Notice is hereby given that on April 7, 2022, the presiding administrative law judge ("ALJ") issued an Initial Determination on Violation of Section 337. The ALJ also issued a Recommended Determination on remedy and bonding should a violation be found in the above-captioned investigation. The Commission is soliciting submissions on public interest issues raised by the recommended relief should the Commission find a violation. This notice is soliciting comments from the public only.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/04/13/2022-07904/certain-plant-derived-recombinant-human-serum-albumins-rhsa-and-products-containing-same-notice-of)
- API: https://www.federalregister.gov/api/v1/documents/2022-07904

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
